Allograft rejection and glomerular basement membrane antibodies in Alport's syndrome

Journal of Nephrology

Volumn 17, Issue 3, 2004, Pages 431-435

  Charytan, David ^a   Torre, Adriana ^a   Khurana, Mona ^a,c   Nicastri, Anthony ^a   Stillman, Isaac E ^b   Kalluri, Raghu ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Acute allograft rejection; Alport's syndrome; Anti glomerular basement membrane; Autoantibodies; Goodpasture antigen; Kidney transplantation

Indexed keywords

AZATHIOPRINE; COLLAGEN ANTIBODY; COLLAGEN TYPE 4; CYCLOSPORIN; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; RECOMBINANT PROTEIN;

ADULT; ALPORT SYNDROME; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULUS BASEMENT MEMBRANE; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; KIDNEY ALLOGRAFT REJECTION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE PERIOD; PROTEIN DOMAIN; STANDARDIZATION;

ADULT; ANTIBODIES; AUTOANTIBODIES; AUTOANTIGENS; BASEMENT MEMBRANE; COLLAGEN TYPE IV; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GRAFT REJECTION; HUMANS; IMMUNOBLOTTING; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; MALE; NEPHRITIS, HEREDITARY;

EID: 4243091778     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 2003; 348: 2543-56.
2. v.d. Heuvel LP, Schroder CH, Savage CO. The development of anti-glomerular basement membrane nephritis in two children with Alport's syndrome after renal transplantation: characterization of the antibody target. Pediatr Nephrol 1989; 3: 406-13.
3. Dehan P, Van den Heuvel LP, Smeets HJ, Tryggvason K, Foidart JM. Identification of post-transplant anti-alpha 5 (IV) collagen alloantibodies in X-linked Alport syndrome. Nephrol Dial Transplant 1996; 11: 1983-8.
4. Neilson EG, Kalluri R, Sun MJ. Specificity of Goodpasture antoantibodies for the recombinant noncollagenous domains of human type IV collagen. J Biol Chem 1993; 268: 8402-5.
5. Miner JH. Developmental biology of glomerular basement membrane components. Curr Opin Nephrol Hypertens 1998; 7: 13-9.
6. Kashtan CE. Alport syndrome and thin glomerular basement membrane disease. J Am Soc Nephrol 1998; 9: 1736-50.
7. Kalluri R, Shield CF, Todd P, Hudson BG, Neilson EG. Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J Clin Invest 1997; 99: 2470-8.
8. Peten E, Pirson Y, Cosyns JP. Outcome of thirty patients with Alport's syndrome after renal transplantation. Transplantation 1991; 52: 823-6.
9. Bolton WK. Rapidly progressive glomerulonephritis. Semin Nephrol 1996; 16: 517-26.
10. Porter K. Renal transplantation. In Heptinstall R Ed. Pathology of the kidney (4 edn). Boston: Little, Brown and Company, 1992; 1853-60.
11. Tipping PG, Boyce NG, Holdsworth SR. Relative contributions of chemo-attractant and terminal components of complement to anti-glomerular basement membrane (GBM) glomerulonephritis. Clin Exp Immunol 1989; 78: 444-8.
12. Kalluri R, Petrides S, Wilson CB. Anti-alphal (IV) collagen antoantibodies associated with lung adenocarcinoma presenting as the Goodpasture syndrome. Ann Intern Med 1996; 124: 651-3.
13. Kalluri R, Wilson CB, Weber M. Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome. J Am Soc Nephrol 1995; 6: 1178-85.